Literature DB >> 21058962

Increased serum levels of pigment epithelium-derived factor by excessive alcohol consumption-detection and identification by a three-step serum proteome analysis.

Kazuyuki Sogawa1, Yoshio Kodera, Mamoru Satoh, Yusuke Kawashima, Hiroshi Umemura, Katsuya Maruyama, Hirotaka Takizawa, Osamu Yokosuka, Fumio Nomura.   

Abstract

BACKGROUND: The search for biological markers of alcohol abuse is of continual interest in experimental and clinical alcohol research. We previously used gel-free proteome analysis methods such as the ProteinChip(®) system and the ClinProt™ system to search for new serum markers for alcoholism and found several novel marker candidates. As serum contains thousands of proteins and peptides that are present in a large dynamic concentration, depletion of the abundant proteins and further fractionation of the remainder is necessary to get into the deep proteome. We recently described a simple and highly reproducible three-step method for identifying potential disease-marker candidates among the low-abundance serum proteins.
METHODS: Two serum samples-one on admission and one after 8 weeks of abstinence-were obtained from 8 patients with alcohol dependency. The samples were subjected to a three-step serum proteome analysis. The steps were the following: first, immunodepletion of the 6 most abundant proteins; second, fractionation using reverse-phase high-performance liquid chromatography; and third, separation using one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Differences revealed by protein staining were further confirmed by Western blotting and by enzyme-linked immunosorbent assays (ELISA).
RESULTS: Three-step serum proteome analysis revealed that the serum levels of 5 proteins, alpha2-HS glycoprotein, apolipoprotein A-I, glutathione peroxidase 3, heparin cofactor II, and pigment epithelial-derived factor (PEDF), were significantly greater on admission than after 8 weeks of abstinence. We focused on PEDF because alterations in its levels in alcoholic subjects are not well known. Western blotting and ELISA confirmed the upregulation of PEDF. Serum PEDF levels were significantly greater in moderate to heavy habitual drinkers (14.2 ± 7.7 μg/ml) than in healthy subjects without a drinking history (5.5 ± 3.0 μg/ml) (p < 0.001). The serum PEDF levels in subjects with nonalcoholic chronic liver diseases were comparable to the PEDF levels in healthy subjects.
CONCLUSION: Three-step serum proteome analysis reveals that excessive alcohol drinking increases the PEDF level.
Copyright © 2010 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21058962     DOI: 10.1111/j.1530-0277.2010.01336.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  12 in total

1.  Familial risk for alcohol dependence and developmental changes in BMI: the moderating influence of addiction and obesity genes.

Authors:  Sarah D Lichenstein; Bobby L Jones; Jessica W O'Brien; Nicholas Zezza; Scott Stiffler; Brian Holmes; Shirley Y Hill
Journal:  Pharmacogenomics       Date:  2014-07       Impact factor: 2.533

Review 2.  Protein biomarkers of alcohol abuse.

Authors:  Mariana P Torrente; Willard M Freeman; Kent E Vrana
Journal:  Expert Rev Proteomics       Date:  2012-08       Impact factor: 3.940

3.  A dynamic plasma membrane proteome analysis of alcohol-induced liver cirrhosis.

Authors:  Zhenghong Yuan; Xiaofang Jia; Lin Yin; Yanling Feng; Xia Peng; Fang Ma; Yamin Yao; Xiaoqian Liu; Zhiyong Zhang; Lijun Zhang
Journal:  Proteome Sci       Date:  2012-06-08       Impact factor: 2.480

4.  Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model.

Authors:  M L Broadhead; C R Dass; P F M Choong
Journal:  Br J Cancer       Date:  2011-10-06       Impact factor: 7.640

5.  Efficacy of continuously administered PEDF-derived synthetic peptides against osteosarcoma growth and metastasis.

Authors:  Matthew L Broadhead; Peter F M Choong; Crispin R Dass
Journal:  J Biomed Biotechnol       Date:  2012-05-30

6.  Urinary albumin and transferrin as early diagnostic markers of chronic kidney disease.

Authors:  Hiroto Maeda; Kazuyuki Sogawa; Kazuko Sakaguchi; Saori Abe; Wataru Sagizaka; Shunsuke Mochizuki; Waka Horie; Toshifumi Watanabe; Yui Shibata; Mamoru Satoh; Akihiro Sanda; Fumio Nomura; Jun Suzuki
Journal:  J Vet Med Sci       Date:  2015-03-28       Impact factor: 1.267

Review 7.  Biomarkers of alcohol misuse: recent advances and future prospects.

Authors:  Iwona Jastrzębska; Agnieszka Zwolak; Michał Szczyrek; Agnieszka Wawryniuk; Barbara Skrzydło-Radomańska; Jadwiga Daniluk
Journal:  Prz Gastroenterol       Date:  2016-06-08

8.  Pigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosis.

Authors:  Joanna Kozlowska; Tomasz Mikula; Magdalena Suchacz; Joanna Jabnonska; Wojciech Stanczak; Janusz Cianciara; Alicja Wiercinska-Drapalo
Journal:  Saudi J Gastroenterol       Date:  2016 Sep-Oct       Impact factor: 2.485

9.  The application of a three-step serum proteome analysis for the discovery and identification of novel biomarkers of hepatocellular carcinoma.

Authors:  Asako Kimura; Kazuyuki Sogawa; Mamoru Satoh; Yoshio Kodera; Osamu Yokosuka; Takeshi Tomonaga; Fumio Nomura
Journal:  Int J Proteomics       Date:  2012-08-16

10.  Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.

Authors:  Kazuyuki Sogawa; Shigetsugu Takano; Fumie Iida; Mamoru Satoh; Sachio Tsuchida; Yusuke Kawashima; Hideyuki Yoshitomi; Akihiro Sanda; Yoshio Kodera; Hirotaka Takizawa; Rintaro Mikata; Masayuki Ohtsuka; Hiroaki Shimizu; Masaru Miyazaki; Osamu Yokosuka; Fumio Nomura
Journal:  Br J Cancer       Date:  2016-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.